EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

The role of anti-HLA antibodies in the prevention, diagnosis, and management of antibody-mediated rejection after kidney transplant

A. G. Balkarov, N. V. Borovkova, Yu. A. Anisimov, N. A. Mushta, N. V. Shmarina, N. V. Doronina, V. V. Smirnova, I. V. Dmitriev

Russian Journal of Transplantology and Artificial Organs · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background . The available literature contains relatively few studies investigating the role of anti-human leukocyte antigen (anti-HLA) antibodies – including pre-existing antibodies, de novo synthesized antibodies, and donor-specific antibodies (DSAs) – in the prevention, diagnosis, and treatment of acute kidney transplant (KT) rejection. Materials and methods . We evaluated the prevalence and specificity of pre-existing anti-HLA antibodies, the incidence and specificity of de novo anti-HLA antibody synthesis (including DSAs), and their impact on treatment outcomes at a major national transplant center. A total of 1,663 KTs performed over an 8-year period (2016–2024) were analyzed. The study cohort comprised 962 men (57.8%) and 701 women (42.2%), with a median age of 46 years (interquartile range: 37–55 years). Prior to transplantation, 90.3% of recipients received dialysis-based renal replacement therapy, while 161 patients underwent pre-emptive KT. Results . The presence of pre-existing anti-HLA antibodies was significantly associated with a higher incidence of acute rejection episodes (p < 0.001), increased need for treatment with polyclonal antibodies (p < 0.001), a greater frequency of nonfunctioning kidney grafts (p < 0.001), and higher in-hospital mortality rates (p < 0.001). Similarly, the de novo synthesis of anti-HLA antibodies was significantly associated with an increased incidence of acute rejection (p = 0.004), a greater need for plasmapheresis as part of rejection management (p < 0.001), and a lower likelihood of a functioning kidney graft at the time of hospital discharge (p = 0.037). Conclusion. Despite the high efficacy of modern immunosuppressive regimens, acute rejection remains a major factor compromising kidney graft survival. Assessing the impact of anti-HLA antibodies on KT outcomes therefore remains a pressing issue in modern KT.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
A. G. Balkarov, N. V. Borovkova, Yu. A. Anisimov, N. A. Mushta, N. V. Shmarina, N. V. Doronina, V. V. Smirnova, I. V. Dmitriev
Quelle
Russian Journal of Transplantology and Artificial Organs
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1995-1191
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

A. G. Balkarov, N. V. Borovkova, Yu. A. Anisimov, N. A. Mushta, N. V. Shmarina, N. V. Doronina, V. V. Smirnova, I. V. Dmitriev (2026). The role of anti-HLA antibodies in the prevention, diagnosis, and management of antibody-mediated rejection after kidney transplant. Russian Journal of Transplantology and Artificial Organs. https://doi.org/10.15825/1995-1191-2026-3-107-114
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1